Navigation Links
MIT: Novel needle could cut medical complications
Date:4/2/2009

CAMBRIDGE, Mass.--Each year, hundreds of thousands of people suffer medical complications from hypodermic needles that penetrate too far under their skin. A new device developed by MIT engineers and colleagues aims to prevent this from happening by keeping needles on target.

The device, which is purely mechanical, is based on concepts borrowed from the oil industry. It involves a hollow S-shaped needle containing a filament that acts as a guide wire. When a physician pushes the device against a tissue, she is actually applying force only to the filament, not the needle itself, thanks to a special clutch.

When the filament, which moves through the tip of the needle, encounters resistance from a firm tissue, it begins to buckle within the S-shaped tube. Due to the combined buckling and interactions with the walls of the tube, the filament locks into place "and the needle and wire advance as a single unit," said Jeffrey Karp, an affiliate faculty member of the Harvard-MIT Division of Health Sciences and Technology (HST) and co-corresponding author of a recent paper on the work in the Proceedings of the National Academy of Sciences.

The needle and wire proceed through the firm tissue. But once they reach the target cavity (for example, a blood vessel) there is no more resistance on the wire, and it quickly advances forward while the needle remains stationary. Because the needle is no longer moving, it cannot proceed past the cavity into the wrong tissue.

Karp believes that the device could reach clinics within three to five years pending further pre-clinical and clinical testing.

First author Erik K. Bassett, now at Massachusetts General Hospital (MGH), developed the device for his MIT master's thesis. He did so under Alexander Slocum, the Neil and Jane Pappalardo Professor of Mechanical Engineering, with guidance from Karp and Omid Farokhzad of HST, Harvard Medical School (HMS) and Brigham and Women's Hospital (
'/>"/>

Contact: Elizabeth Thomson
thomson@mit.edu
617-258-5402
Massachusetts Institute of Technology
Source:Eurekalert

Page: 1 2

Related biology news :

1. MGH researchers describe new way to identify, evolve novel enzymes
2. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
3. Novel 3-D cell culture model shows selective tumor uptake of nanoparticles
4. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
5. IdentiPHI Re Launches SAFmodule Software to Secure Novell(R) Networks
6. 454 Sequencing: Science paper describes a novel, highly efficient method of sequencing ancient DNA
7. Scientists discover novel way to remove iron from ferritin
8. Identification of a novel class of (not-so) small RNAs
9. A novel way found to prevent protein plaques implicated in Alzheimers
10. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
11. Feinstein researchers develop new genetic method and identify novel genes for schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... at the right time might actually help boost a ... help in understanding animal populations, pest control and managing ... the journal Trends in Ecology and Evolution , ... the kind of positive population effect an overall species ... on the size and developmental stage of the creatures ...
(Date:11/4/2014)... about the way our bodies are assembled during early ... they are supposed to become a nerve or a ... correct place and alignment? Researchers at the University of ... a new study, UM researchers describe the signaling systems ... at the head-trunk region. Their discovery may have important ...
(Date:11/4/2014)...   3D scanner ... Fuel3D , a developer of 3D scanning solutions, ... $6.4 million (£4 million). This funding builds on the company,s ... and paves the way for the commercial launch of the ... round was led by Chimera Partners and will be used ...
Breaking Biology News(10 mins):When less is more: Death in moderation boosts population density in nature 2The inside story: How the brain and skull stay together 2Fuel3D Secures $6.4 Million in Expansion Funding 2Fuel3D Secures $6.4 Million in Expansion Funding 3
... study from Rhode Island Hospital has found that a change ... contribute to improved outcomes of the victims and to the ... enforcement officers often serve as medical first responders, there is ... or should do, at the scene of an overdose. The ...
... MedNet Solutions , a global life sciences technology ... to announce that Accelovance , an award-winning, full-service ... Vaccines and General Medicine development, has joined the ... as an iMedNet Partner will facilitate Accelovance,s ...
... of Helsinki and Folkhlsan Research Center has identified a ... breeds, the Norwegian Elkhound and the Karelian Bear Dog. ... and a candidate gene for human chondrodysplasias. The finding ... health. A genetic test can now be used to ...
Cached Biology News:Changing laws, attitudes of police response to drug overdose may lead to better outcomes 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 2MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program 3New dwarfism mutation identified in dogs 2
(Date:11/26/2014)... 26, 2014 PMG Research, Inc. ... Research is a network of sites that provide clinical research ... 2 million patient lives through its partnerships with large physician ... 11 hub site locations in the Southeastern United States and ... of the board will be held by: Dr. ...
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... Boston, MA (PRWEB) November 26, 2014 ... and collaboration company is proud to announce that Darren ... Development and Sales. Darren will drive the ... and positive customer experience. , Darren brings ... He has held key roles in channel operations, from ...
(Date:11/26/2014)... MINNEAPOLIS , Nov. 25, 2014 Bio-Techne ... it has appointed Robert Gavin to serve ... of the Protein Platforms Division.  Mr. Gavin will be ... business segment, which includes the ProteinSimple business acquired in ... San Jose, California -based ProteinSimple ...
Breaking Biology Technology:PMG Research Names Medical Advisory Board 2PMG Research Names Medical Advisory Board 3Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2SoundConnect Appoints Director of Channel Development & Sales 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 2Bio?Techne Announces Appointment Of Robert Gavin As Leader Of New Protein Platforms Division 3
... Neuralstem, Inc. (NYSE Alternext US: CUR) announced ... present at the 11th Annual BIO CEO & ... 2009, at the Waldorf=Astoria Hotel, New York City.(Logo: ... February 9, 2009 at 10:00 a.m. Eastern Time.The ...
... Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, ... all the technology and intellectual property for a suite ... in three gastrointestinal cancers. Cancer Advances was created as ... products developed to inhibit the hormone, gastrin, for an ...
... First proton pump inhibitor (PPI) with a ... OSAKA, Japan, Jan. 30 Takeda Pharmaceutical ... Pharmaceuticals North America, Inc., today announced that ... approved KAPIDEX(TM) (dexlansoprazole) delayed release capsules for ...
Cached Biology Technology:Neuralstem to Present at the 11th Annual BIO CEO & Investor Conference 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 2Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 2FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 3FDA Approves KAPIDEX(TM) (Dexlansoprazole) delayed release capsules for the Treatment of GERD 4